American Academy of Dermatology Releases Sunscreen Safety Statement
AAD/AADA President George J. Hruza, MD, MBA, FAAD, releases a statement regarding recent reports about sunscreen safety.
AAD/AADA President George J. Hruza, MD, MBA, FAAD, releases a statement regarding recent reports about sunscreen safety.
The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.